Skip to content

Molecular Identification of Major Allergens of Artemisia ordosica Pollen, Characterization of Clinical Sensitization Profiles, and Its Application in Diagnosis and Immunotherapeutic Preparations

Molecular Identification of Major Allergens of Artemisia ordosica Pollen, Characterization of Clinical Sensitization Profiles, and Its Application in Diagnosis and Immunotherapeutic Preparations

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600130077
Enrollment
Unknown
Registered
2026-08-14
Start date
2026-08-20
Completion date
Unknown
Last updated
2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis

Interventions

Healthy control:None

Sponsors

The First Affiliated Hospital of Xi 'an Jiaotong University Yulin Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Male or female subjects aged >=18 and =18 and <=65 years old; 6. Control group: individuals without the aforementioned allergic rhinitis symptoms.

Exclusion criteria

Exclusion criteria: 1.Patients with malignant tumors; 2.Pregnant or lactating women; 3.Subjects with severe underlying diseases involving the liver, kidney, heart, hematopoietic system, nervous system or psychiatric disorders; 4.Any other conditions deemed inappropriate for enrollment by the investigators.

Design outcomes

Primary

MeasureTime frame
Allergen-induced mast cell activation assessment;Identification and characterization of IgE-binding allergens from Artemisia ordosica pollen;Diagnostic performance of component-resolved allergen-specific IgE detection;Immunoreactivity evaluation of recombinant major Artemisia ordosica pollen allergens;

Secondary

MeasureTime frame
Integrated transcriptomic and proteomic analysis for mechanism exploration;Peripheral immune profile and IgE-associated inflammatory characteristics;Immunomodulatory effects of hypoallergenic allergen immunotherapy candidates;Analytical performance and consistency evaluation of allergen-specific IgE detection methods;

Countries

China

Contacts

Public ContactHao Wendong

The First Affiliated Hospital of Xi 'an Jiaotong University Yulin Hospital

hwdokgood@hotmail.com+86 912 3687695

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026